Chordate Medical Holding AB (publ)

Stockholm Stock Exchange CMH.ST

Chordate Medical Holding AB (publ) Market Capitalization on January 14, 2025: USD 1.57 M

Chordate Medical Holding AB (publ) Market Capitalization is USD 1.57 M on January 14, 2025, a -67.46% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Chordate Medical Holding AB (publ) 52-week high Market Capitalization is USD 6.20 M on January 30, 2024, which is 295.78% above the current Market Capitalization.
  • Chordate Medical Holding AB (publ) 52-week low Market Capitalization is USD 854.15 K on January 03, 2025, which is -45.44% below the current Market Capitalization.
  • Chordate Medical Holding AB (publ) average Market Capitalization for the last 52 weeks is USD 2.90 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Stockholm Stock Exchange: CMH.ST

Chordate Medical Holding AB (publ)

CEO Mr. Anders Weilandt
IPO Date Feb. 15, 2022
Location Sweden
Headquarters KistagAngen 20B
Employees 3
Sector Health Care
Industries
Pharmaceuticals
Description

Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.

Similar companies

CLS-B.ST

Clinical Laserthermia Systems AB (publ)

USD 0.28

-7.61%

StockViz Staff

January 15, 2025

Any question? Send us an email